Roivant Sciences Ltd.

NasdaqGS:ROIV

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United Kingdom

Market Cap

USD 7.78 B

Share Price

USD 11.40

Avg Daily Volume

5,955,954

Change (1 day)

-0.18%

Change (1 year)

6.84%

Change (YTD)

-3.64%

Roivant Sciences Ltd. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -839.45 M

Roivant Sciences Ltd. Operating Cash Flow is USD -839.45 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 18.54% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Roivant Sciences Ltd. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD -708.16 M.
Roivant Sciences Ltd. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -582.14 M.